Axovant Gene Therapies Ltd.
Axovant Gene Therapies Ltd. (AXGT) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 12 transactions totaling $20.2M, demonstrating a bullish sentiment with $20.2M in net insider flow. The most recent transaction on Jul 8, 2020 involved a purchase of 37,500 shares valued at $102.8K.
AXGT Insider Activity Summary
Who Is Buying AXGT Stock?
No significant insider buying has been recorded for AXGT in the recent period.
Who Is Selling AXGT Stock?
No significant insider selling has been recorded for AXGT in the recent period.
Is Axovant Gene Therapies Ltd. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AXGT is bullish with an Insider Alignment Score of 100/100 and a net flow of $20.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
AXGT Frequently Asked Questions
Understanding AXGT Insider Activity
Insider trading at Axovant Gene Therapies Ltd. (AXGT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading AXGT stock, having executed 12 transactions in the past 90 days. The most active insider is Sciences Ltd. Roivant (Executive), who has made 1 transactions totaling $20.0M.
Related Tools
Track Axovant Gene Therapies Ltd. Insider Activity
Get notified when executives and directors at AXGT file new Form 4 transactions